Loading...
Oncology Pharma Inc.
ONPH•PNK
HealthcareBiotechnology
$0.00
$0.00(0.00%)
Oncology Pharma Inc. (ONPH) Stock Overview
Explore Oncology Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for ONPHStats details for ONPH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ONPHAnalyst Recommendations details for ONPH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
CEO
Mr. George Malesek
Headquarters
1 Sansome Street, San Francisco, CA
Founded
1994